Terms: = Testicular cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Clinical Outcome
11 results:
1. Bleomycin-induced pneumonitis in three patients treated with chemotherapy for primary advanced seminoma.
Stein ME; Zidan J; Charas T; Gershuny A; Ben-Yosef R
J BUON; 2015; 20(3):928-32. PubMed ID: 26214649
[TBL] [Abstract] [Full Text] [Related]
2. clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease.
Nicolai N; Necchi A; Raggi D; Biasoni D; Catanzaro M; Piva L; Stagni S; Maffezzini M; Torelli T; Faré E; Giannatempo P; Pizzocaro G; Colecchia M; Salvioni R
Urology; 2015 Feb; 85(2):402-6. PubMed ID: 25623702
[TBL] [Abstract] [Full Text] [Related]
3. Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.
Cathomas R; Klingbiel D; Geldart TR; Mead GM; Ellis S; Wheater M; Simmonds P; Nagaraj N; von Moos R; Fehr M
Ann Oncol; 2014 Aug; 25(8):1591-7. PubMed ID: 24669017
[TBL] [Abstract] [Full Text] [Related]
4. 2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.
Bachner M; Loriot Y; Gross-Goupil M; Zucali PA; Horwich A; Germa-Lluch JR; Kollmannsberger C; Stoiber F; Fléchon A; Oechsle K; Gillessen S; Oldenburg J; Cohn-Cedermark G; Daugaard G; Morelli F; Sella A; Harland S; Kerst M; Gampe J; Dittrich C; Fizazi K; De Santis M
Ann Oncol; 2012 Jan; 23(1):59-64. PubMed ID: 21460378
[TBL] [Abstract] [Full Text] [Related]
5. Role of 14-3-3σ in poor prognosis and in radiation and drug resistance of human pancreatic cancers.
Li Z; Dong Z; Myer D; Yip-Schneider M; Liu J; Cui P; Schmidt CM; Zhang JT
BMC Cancer; 2010 Nov; 10():598. PubMed ID: 21040574
[TBL] [Abstract] [Full Text] [Related]
6. The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.
Carver BS; Cronin AM; Eggener S; Savage CJ; Motzer RJ; Bajorin D; Bosl GJ; Sheinfeld J
Urology; 2010 Jun; 75(6):1431-5. PubMed ID: 20299079
[TBL] [Abstract] [Full Text] [Related]
7. 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.
De Santis M; Becherer A; Bokemeyer C; Stoiber F; Oechsle K; Sellner F; Lang A; Kletter K; Dohmen BM; Dittrich C; Pont J
J Clin Oncol; 2004 Mar; 22(6):1034-9. PubMed ID: 15020605
[TBL] [Abstract] [Full Text] [Related]
8. clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma.
Rabbani F; Farivar-Mohseni H; Leon A; Motzer RJ; Bosl GJ; Sheinfeld J
Urology; 2003 Dec; 62(6):1092-6. PubMed ID: 14665362
[TBL] [Abstract] [Full Text] [Related]
9. A case for synchronous reduction of testicular androgen, adrenal androgen and prolactin for the treatment of advanced carcinoma of the prostate.
Rana A; Habib FK; Halliday P; Ross M; Wild R; Elton RA; Chisholm GD
Eur J Cancer; 1995 Jun; 31A(6):871-5. PubMed ID: 7646913
[TBL] [Abstract] [Full Text] [Related]
10. Difference in DNA index of seminomas and non-seminomas.
Fischer CG; Weidner W; Schroeder-Printzen I; Kallerhof M; Ringert RH
Andrologia; 1994; 26(6):337-41. PubMed ID: 7872508
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
[TBL] [Abstract] [Full Text] [Related]
